Angiotensin II receptor blockers (ARBs)
Drug Safety Update
Drug Safety Update April 2020: Coronavirus (COVID-19): latest guidance on medicines safety - antihypertensives
February 2016: Co-prescribing an ACE inhibitor or Angiotensin-II receptor antagonists with potassium sparing diuretics - risk of fatal hyperkalaemia
June 2014: Safety concerns when combining medicines from different classes of renin-angiotensin system blocking agents - this combination is not recommended.
May 2009: ACE inhibitors and Angiotensin-II receptor antagonists should not be used by breast feeding mothers in the first few weeks after delivery.
Dec 2007: ACE inhibitors and Angiotensin-II receptor antagonists should not be used at any stage during pregnancy
NICE guidance
NG136: Hypertension in adults: diagnosis and management
| Pack |
|---|
| 7 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| 7 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
| 56 tablet |
| 7 tablet |
| 84 tablet |
| Pack |
|---|
| 10 tablet |
| 28 tablet |
| 30 tablet |
| 56 tablet |
| 84 tablet |
| Pack |
|---|
| 28 tablet |
| 56 tablet |
| 84 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| 84 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 capsule |
| 7 capsule |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 14 capsule |
| 28 capsule |
| 98 capsule |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary